✦ LIBER ✦

Donepezil treatment's late effects on cytokines release from lymphocytes of Alzheimer's disease patients

✍ Scribed by Evaggelia Stamouli; Christina Piperi; Everina Katirtzoglou; Kostantinos Siarkos; Maria Passa; Antonis Maillis; George Papadimitriou; Antonis Politis

Book ID: 118468251
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 95 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.286

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of donepezil on apathy in pa

The effects of donepezil on apathy in patients with Alzheimer's disease

✍ Waldemar, Gunhild; Xu, Yikang; Mackell, Joan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Effect of memantine treatment at patient

Effect of memantine treatment at patients with moderate - severe Alzheimer's disease treated with Donepezil

✍ A.S. Szalontay; R. Chirita; V. Chirita 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 40 KB

Effectiveness of donepezil on behavioral

Effectiveness of donepezil on behavioral disturbances in mild to moderate Alzheimer's disease patients

✍ Thomas McRae; Teresa Griesing; Ed Whalen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Donepezil treatment of Alzheimer's disea

Donepezil treatment of Alzheimer's disease patients in California clinical practice: One year follow-up

✍ J. Tinklenberg; L. Newkirk; J. Thompson; L. Ross; H. Davies; R. Shakoori; J. Tay 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Acetylcholinesterase inhibitors effects

Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1β and interleukin-6 release from lymphocytes of Alzheimer's disease patients

✍ Marcella Reale; Carla Iarlori; Francesco Gambi; Isabella Lucci; Mirella Salvator 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving